Joseph Lacy, MD, Neurologist, Palo Alto Medical Foundation

California Pacific CURRENTS: The online journal of CPMC Research Institute

Advancing the treatment of multiple sclerosis

Research Overview

  • Joseph Lacy, MD, is a neurologist at Palo Alto Medical Foundation. During his training at the University of Pennsylvania, he developed an interest in neuroimmunologic disorders.
  • He was a fellow at the National Institutes of Health, and later, as an Assistant Professor of Neurology at the University of Colorado, he conducted clinical trials in the treatment of demyelinating neuropathies.
  • After coming to Palo Alto Medical Foundation in 1982, Dr. Lacy continued to be involved in clinical trials including investigational trials in epilepsy, stroke and multiple sclerosis (MS). In addition to his general neurology practice, he ultimately became focused on the care and treatment of patients with MS. For example, Dr. Lacy was involved in clinical trials of one of the original disease modifying therapies for MS, copolymer-1, and has also been involved in research of clinical biomarkers in MS and investigations of the JC virus antibody status of patients with the illness.
  • Dr. Lacy has recently completed a five-year term as Chairman of the Board of Directors of the Palo Alto Foundation Medical Group. He has now resumed an active clinical practice and anticipates ongoing involvement in clinical trials as a member of the Sutter Neuroscience Research Consortium.


Dr. Lacy received his MD from the University of Vermont. He completed residency training at the University of California, Irvine, and at the University of Pennsylvania. He completed fellowship training at the National Institute of Neurological Communicative Disorders and Stroke, and at the National Institutes of Health.

Publication Search


Kushner JP, Lacy JA, Gay SR, Nutritional Support on the Medical Wards--Thought for Food. JAMA Intern Med

Kantor AB, Deng J, Waubant E, Lin H, Becker CH, Lacy JR, Perrone AM, Bennett D, Goelz SE, Identification of short-term pharmacodynamic effects of interferon-beta-1a in multiple sclerosis subjects with broad- based phenotypic profiling. J Neuroimmunol

Joseph Lacy, MD, Neurologist, Palo Alto Medical Foundation
Primary Research Interests
  • General neurology
  • Multiple sclerosis
  • Electromyography
  • Nerve and muscle disease